Immatics (IMTX) Current Deferred Revenue (2019 - 2025)

Immatics recorded quarterly Current Deferred Revenue of $21.6 million in Q4 2025, down 27.78% quarter-over-quarter from $29.9 million in Q3 2025, and down 43.75% year-over-year from $38.4 million in Q4 2024.

Immatics' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $21.6 million for Q4 2025.

  • In Q4 2025, Current Deferred Revenue fell 43.75% year-over-year to $21.6 million; the TTM figure through Dec 2025 stood at $21.6 million (down 43.75% YoY), while the FY2025 annual figure was $20.9 million, down 45.41% from the prior year.
  • Current Deferred Revenue came in at $21.6 million for Q4 2025 at Immatics, down from $29.9 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $124.3 million in Q4 2023 to a low of $21.6 million in Q4 2025.
  • A 5-year average of $71.6 million and a median of $73.5 million in 2021 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue surged 87.56% in 2023 and sank 70.74% in 2025, its largest moves.
  • Immatics' Current Deferred Revenue stood at $57.7 million in 2021, then climbed by 14.94% to $66.3 million in 2022, then soared by 87.56% to $124.3 million in 2023, then sank by 69.13% to $38.4 million in 2024, then sank by 43.75% to $21.6 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $21.6 million, $29.9 million, and $31.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Immatics 1.80 Bn 1.80 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 21.58 Mn
Sep 30, 2025 29.88 Mn
Jun 30, 2025 31.20 Mn
Mar 31, 2025 30.68 Mn
Dec 31, 2024 38.37 Mn
Sep 30, 2024 75.70 Mn
Jun 30, 2024 102.87 Mn
Mar 31, 2024 104.86 Mn
Dec 31, 2023 124.30 Mn
Sep 30, 2023 67.55 Mn
Jun 30, 2023 74.04 Mn
Mar 31, 2023 70.07 Mn
Dec 31, 2022 66.27 Mn
Sep 30, 2022 104.07 Mn
Jun 30, 2022 123.05 Mn
Mar 31, 2022 76.08 Mn
Dec 31, 2021 57.66 Mn
Sep 30, 2021 72.97 Mn
Jun 30, 2021 74.91 Mn
Mar 31, 2021 86.50 Mn
Dec 31, 2020 101.91 Mn
Sep 30, 2020 93.79 Mn
Jun 30, 2020 90.91 Mn
Dec 31, 2019 51.58 Mn